NCT00140088View on ClinicalTrials.gov

Efficacy and Safety of ALGRX 3268 in Management of Needlestick Pain in Children.

PHASE3CompletedINTERVENTIONAL
Enrollment

504

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

April 30, 2005

Conditions
Procedural Pain
Interventions
DRUG

ALGRX 3268

Trial Locations (1)

06106

Connecticut Children's Medical Center, Hartford

Sponsors
All Listed Sponsors
lead

AlgoRx Pharmaceuticals

INDUSTRY

NCT00140088 - Efficacy and Safety of ALGRX 3268 in Management of Needlestick Pain in Children. | Biotech Hunter | Biotech Hunter